[GARDP Press Release] [Geneva/San Francisco/Brisbane/Saarbrücken – 11 April 2019]  Multi-actor partnership tests natural products and compound libraries for antibacterial activity Discovery efforts will focus on World Health Organization’s (WHO) priority pathogens  The Global Antibiotic Research and Development Partnership (GARDP) is partnering with Calibr, the Helmholtz Centre for Infection Research (HZI), in particular its location Helmholtz-Institute […] Continue reading ->
Drummers, dancers, and speakers blasting Lady Gaga for a crowd of five hundred people linking hands and doing the wave is not the image typically conjured up when one hears of a World Health Organization event. A crowd gathered beneath a small stage decorated with slogans championing universal health coverage. Despite the morning’s chill lingering […] Continue reading ->
The global health organisation Vital Strategies has become a leading actor in the worldwide battle against obesity, which affects 2 billion people globally. Building on its tradition of working to cut tobacco consumption and traffic injuries, the organisation tackled sugary drink consumption as a flagship issue for policy change. While the famous 2013 “soda ban” […] Continue reading ->
[DNDi Press Release] Geneva, Switzerland – 2 April 2019 Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun […] Continue reading ->
[WHO News Release] From Geert Cappelaere, UNICEF Regional Director in the Middle East and North Africa and Dr Ahmed Al Mandhari, WHO Regional Director for the Eastern Mediterranean MUSCAT/ AMMAN/CAIRO, 26 March 2019 – “In Yemen, since the beginning of the year until 17 March, nearly 109 000 cases of severe acute watery diarrhoea and suspected […] Continue reading ->